ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 180 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $625,000 | +7.0% | 100,000 | 0.0% | 0.01% | +14.3% |
Q3 2015 | $584,000 | -29.4% | 100,000 | 0.0% | 0.01% | -22.2% |
Q2 2015 | $827,000 | +0.4% | 100,000 | 0.0% | 0.01% | -10.0% |
Q1 2015 | $824,000 | +19.9% | 100,000 | 0.0% | 0.01% | +25.0% |
Q4 2014 | $687,000 | +27.2% | 100,000 | 0.0% | 0.01% | +14.3% |
Q3 2014 | $540,000 | -15.2% | 100,000 | 0.0% | 0.01% | -12.5% |
Q2 2014 | $637,000 | -21.0% | 100,000 | 0.0% | 0.01% | -27.3% |
Q1 2014 | $806,000 | -83.7% | 100,000 | -86.2% | 0.01% | -89.2% |
Q4 2013 | $4,945,000 | – | 725,000 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 12,850,000 | $175,916,000 | 40.51% |
Consonance Capital Management LP | 8,695,742 | $119,045,000 | 11.46% |
Tamarack Advisers, LP | 3,700,000 | $49,358,000 | 7.76% |
Opaleye Management Inc. | 1,045,000 | $14,306,000 | 7.49% |
Granite Point Capital Management, L.P. | 457,415 | $6,262,000 | 2.44% |
Redmile Group, LLC | 2,138,471 | $29,276,000 | 2.33% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 206,010 | $2,820,000 | 2.17% |
Palo Alto Investors LP | 2,587,617 | $35,424,000 | 2.06% |
PRICE MICHAEL F | 940,000 | $12,869,000 | 1.71% |
HighVista Strategies LLC | 638,086 | $8,735,000 | 1.62% |